Literature DB >> 24424455

Crossing barriers; restoring barriers? Filaggrin protein replacement takes a bow.

Alan D Irvine1.   

Abstract

In this issue of the Journal, Stout and colleagues report a novel and creative approach to replacement of genetically determined absence or deficiency of epidermal proteins. While these early data are certainly interesting, further validation work is required to determine the utility of this approach in genodermatoses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24424455     DOI: 10.1038/jid.2013.506

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis.

Authors:  Alan D Irvine; W H Irwin McLean
Journal:  J Invest Dermatol       Date:  2006-06       Impact factor: 8.551

2.  Recombinant filaggrin is internalized and processed to correct filaggrin deficiency.

Authors:  Thomas E Stout; Trevor McFarland; John C Mitchell; Binoy Appukuttan; J Timothy Stout
Journal:  J Invest Dermatol       Date:  2013-06-21       Impact factor: 8.551

3.  Filaggrin in the frontline: role in skin barrier function and disease.

Authors:  Aileen Sandilands; Calum Sutherland; Alan D Irvine; W H Irwin McLean
Journal:  J Cell Sci       Date:  2009-05-01       Impact factor: 5.285

Review 4.  The multifunctional role of filaggrin in allergic skin disease.

Authors:  Maeve A McAleer; Alan D Irvine
Journal:  J Allergy Clin Immunol       Date:  2013-02       Impact factor: 10.793

5.  Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease.

Authors:  Elke Rodríguez; Hansjörg Baurecht; Esther Herberich; Stefan Wagenpfeil; Sara J Brown; Heather J Cordell; Alan D Irvine; Stephan Weidinger
Journal:  J Allergy Clin Immunol       Date:  2009-06       Impact factor: 10.793

6.  Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity.

Authors:  S Kezic; G M O'Regan; N Yau; A Sandilands; H Chen; L E Campbell; K Kroboth; R Watson; M Rowland; W H Irwin McLean; A D Irvine
Journal:  Allergy       Date:  2011-01-25       Impact factor: 13.146

7.  Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect.

Authors:  Sara J Brown; Karin Kroboth; Aileen Sandilands; Linda E Campbell; Elizabeth Pohler; Sanja Kezic; Heather J Cordell; W H Irwin McLean; Alan D Irvine
Journal:  J Invest Dermatol       Date:  2011-11-10       Impact factor: 8.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.